Pipeline
Addition Therapeutics has multiple rare (genetic) and chronic (non-genetic) preclinical programs, some fully owned, some in conjunction with collaborators. More details to come soon!
Partnership inquiries:
bd@additiontx.com
Addition Therapeutics has multiple rare (genetic) and chronic (non-genetic) preclinical programs, some fully owned, some in conjunction with collaborators. More details to come soon!